A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia
Clinical trial NCT02964936 · COMPLETED
Trial details
- NCT number
- NCT02964936
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-11
- Primary completion
- 2018-08-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.